Gara Jalqabaatti › Kansarii Prostate › Connecticut › New Haven
Qorannoo klinikaalii Kansarii Prostate New Haven, CT keessatti
Qorannoo 20 Kansarii Prostate f New Haven fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
- Yale Cancer Center, New Haven
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Yale University, New Haven
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Namoota walitti qabaa jiraSadarkaa 3
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- GSK Investigational Site, New Haven
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Namoota walitti qabaa jiraSadarkaa 2
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven · Miili 3 fagaatti
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Namoota walitti qabaa jiraSadarkaa 3
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0050), New Haven
- Veterans Affairs Connecticut Healthcare System ( Site 0062), West Haven · Miili 3 fagaatti
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Yale Cancer Center, New Haven
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Yale Cancer Center, New Haven
A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
Namoota walitti qabaa jiraQorannoo ilaalaa
- Wren Laboratories, Branford · Miili 6 fagaatti
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Yale New Haven Hospital, New Haven
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Namoota walitti qabaa jiraSadarkaa 2
- New Haven Hospital - Yale Cancer Center, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Yale University School of Medicine, New Haven
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Namoota walitti qabaa jiraSadarkaa 1
- Yale New Haven Hospital, New Haven
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Namoota walitti qabaa jiraSadarkaa 3
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · Miili 3 fagaatti
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Yale University (Data Collection Only), New Haven
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Yale University, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Yale University, Yale Cancer Center, New Haven
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Namoota walitti qabaa jiraSadarkaa 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · Miili 7 fagaatti
- fi 2 dabalataa
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · Miili 3 fagaatti
- Smilow Cancer Hospital Care Center - Guilford, Guilford · Miili 13 fagaatti
Qorannoo Kansarii Prostate magaalota biroo keessatti
- New York City, NYQorannoo 103
- Houston, TXQorannoo 76
- Los Angeles, CAQorannoo 61
- Boston, MAQorannoo 59
- St. Louis, MOQorannoo 46
- Chicago, ILQorannoo 45
- San Francisco, CAQorannoo 45
- Philadelphia, PAQorannoo 44
- Baltimore, MDQorannoo 43
- Nashville, TNQorannoo 42
- Seattle, WAQorannoo 42
- Washington, DCQorannoo 38
Qorannoo biroo New Haven keessatti
- Kansara Qara'a Non-Small CellQorannoo 41
- Saree OljooQorannoo 37
- Saree (Gosoota Hunda)Qorannoo 33
- Kansara MetastatikiiQorannoo 23
- Dhibee QaraQorannoo 22
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 22
- Kansarii OvariiQorannoo 21
- Kansarii ColorectalQorannoo 20
- Overdose OpioidQorannoo 18
- Alcohol Use Disorder (AUD)Qorannoo 17
- Leukemia Myeloidii HamaaQorannoo 17
- Kansarii PancreasQorannoo 16
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.